-
2981
AIDS-Related Non-Hodgkin's Lymphoma in the Era of Highly Active Antiretroviral Therapy
Published 2012-01-01“…Clinical trials investigating the role of allogeneic hematopoietic stem cell transplant in ARL are currently underway.…”
Get full text
Article -
2982
Cellular Plasticity in Prostate Cancer Bone Metastasis
Published 2015-01-01“…An electronic search was performed using PubMed for studies that have examined the differential expression of epithelial, mesenchymal, and stem cell markers in human PC bone metastasis tissues. …”
Get full text
Article -
2983
Prenatal Brain Damage in Preeclamptic Animal Model Induced by Gestational Nitric Oxide Synthase Inhibition
Published 2011-01-01Get full text
Article -
2984
A 58-Year-Old Female with Progressive Cough and Right Shoulder Pain
Published 2016-01-01“…Establishing accurate diagnosis and starting effective antibiotics are essential steps towards improving outcome. A 58-year-old stem cell transplant patient was admitted to the hospital with necrotizing pneumonia caused by nocardia. …”
Get full text
Article -
2985
-
2986
Discovering CRISPR-Cas system with self-processing pre-crRNA capability by foundation models
Published 2024-11-01Get full text
Article -
2987
Effects of RARα ligand binding domain mutations on breast fibroepithelial tumor function and signaling
Published 2025-01-01Get full text
Article -
2988
Apoptotic Vesicles Attenuate Acute Lung Injury via CD73-Mediated Inhibition of Platelet Activation and NETosis
Published 2025-01-01“…To date, no pharmacological treatment has proven effective for ARDS. Mesenchymal stem cell-derived apoptotic vesicles (apoVs) were recently found to have excellent therapeutic potential for inflammatory diseases. …”
Get full text
Article -
2989
-
2990
Regulatory roles of RNA binding proteins in the Hippo pathway
Published 2025-01-01Get full text
Article -
2991
Diagnosis and Management of Atypical Chronic Myeloid Leukemia with a t(2;13)(q33;q12) Translocation
Published 2022-01-01“…Allogeneic hematopoietic stem cell transplant is likely the preferred treatment, but this can be limited by patient psychosocial support, age, concomitant medical conditions, and availability of an appropriate donor. …”
Get full text
Article -
2992
Brentuximab Vedotin Treatment for Primary Refractory Hodgkin Lymphoma
Published 2013-01-01“…With intensive salvage chemotherapy and autologous stem cell transplantation, the long-term remission rate for these patients was only 30%, but more selective treatments with higher therapeutic index are needed. …”
Get full text
Article -
2993
Frailty-adjusted therapy in Transplant Non-Eligible patients with newly diagnosed Multiple Myeloma (FiTNEss (UK-MRA Myeloma XIV Trial)): a study protocol for a randomised phase III...
Published 2022-06-01“…However, this is less apparent in older, less fit patients, who are ineligible for stem cell transplant. Research is required in this patient group, taking into account frailty and aiming to improve: treatment tolerability, clinical outcomes and quality of life.Methods and analysis Frailty-adjusted therapy in Transplant Non-Eligible patients with newly diagnosed Multiple Myeloma is a national, phase III, multicentre, randomised controlled trial comparing standard (reactive) and frailty-adjusted (adaptive) induction therapy delivery with ixazomib, lenalidomide and dexamethasone (IRD), and to compare maintenance lenalidomide to lenalidomide+ixazomib, in patients with newly diagnosed multiple myeloma not suitable for stem cell transplant. …”
Get full text
Article -
2994
-
2995
Synthetic embryology of the human heart
Published 2025-01-01“…The evolution of stem cell-based heart models from cells and tissues to organoids and assembloids and recently synthetic embryology gastruloids, is poised to revolutionize our understanding of cardiac development, congenital to adult diseases, and patient customized therapies. …”
Get full text
Article -
2996
Serum Cytokine Profile in a Patient Diagnosed with Dysferlinopathy
Published 2017-01-01Get full text
Article -
2997
Novel approaches in myelofibrosis
Published 2024-12-01“…Currently, the management of MF patients is tailored according to risk scores, with higher‐risk (intermediate‐2 and high‐risk) patients being assessed for allogeneic stem cell transplantation, which remains the only potentially curative treatment option. …”
Get full text
Article -
2998
The Burden of Cost in Bronchiolitis Obliterans Syndrome: Predictions for the Next Decade
Published 2016-06-01“…The most common life-threatening complication of lung and hematopoietic stem-cell transplantation (HSCT) is bronchiolitis obliterans syndrome (BOS). …”
Get full text
Article -
2999
-
3000
The association between the dietary inflammatory index and multiple myeloma: a case–control study
Published 2025-01-01Get full text
Article